Medical Countermeasures Strategic Planning and Committees

ASPR has both important policy and operational responsibilities related to the advanced research and development and procurement of medical countermeasures (MCMs). Within ASPR, BARDA provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.

In addition, ASPR leads federal coordination efforts to enhance chemical, biological, radiological and nuclear threats and emerging infectious diseases preparedness from a medical countermeasure perspective through the Public Health Emergency Medical Countermeasures Enterprise and ASPR coordinates the National Biodefense Science Board.